Ocular Pharmacokinetics of AzaSite Xtra—2% Azithromycin Formulated in a DuraSite Delivery System

Author： Si Erwin   Cheung Paul   Bowman Lyle   Hosseini Kamran  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.34, Iss.6, 2009-06, pp. : 485-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Boston Ocular Surface Prosthesis as a Novel Drug Delivery System for Bevacizumab

By Lim Mira   Jacobs Deborah   Rosenthal Perry   Carrasquillo Karen  

Seminars in Ophthalmology, Vol. 24, Iss. 3, 2009-05 ,pp. : 149-155

Informa Healthcare

Access to resources Recommend Favorite

Ocular penetration of topical ?9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site

By Green Keith   Kearse E. Claire  

Current Eye Research, Vol. 21, Iss. 1, 2000-07 ,pp. : 566-570

Informa Healthcare

Access to resources Recommend Favorite

The Ocular Pharmacokinetics of Topical Diclofenac Is Affected by Ocular Inflammation

By  

Ophthalmic Research, Vol. 31, Iss. 4, 1999-05 ,pp. : 309-316

Karger

Access to resources Recommend Favorite

Advances in Ocular Drug Delivery

By Rawas-Qalaji Mutasem   Williams Cheryl-Ann  

Current Eye Research, Vol. 37, Iss. 5, 2012-05 ,pp. : 345-356

Informa Healthcare

Access to resources Recommend Favorite

Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats

By Wang Siling   Li Dexin   Ito Yoshimasa   Nabekura Tomohiro   Wang Shujun   Zhang Jinghai   Wu Chunfu  

Current Eye Research, Vol. 29, Iss. 1, 2004-07 ,pp. : 51-58

Informa Healthcare

Access to resources Recommend Favorite